Tevogen (TVGNW) Stock: Why It's Down Today
Updated Oct 19, 2026, 4:00 PM ET · closing price
- Closed at $0.06, -7.69% vs the prior close of $0.07.
- Volume 752.00K shares, 6.6x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
TVGNW slides 7.7% to $0.06 on 6.6x normal volume. Closed at $0.06, -7.69% vs the prior close of $0.07. Day range $0.04–$0.07, opened at $0.05.
TVGNW daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — TVGNW slides 7.7% to $0.06 on 6.6x normal volume
- Closed at $0.06, -7.69% vs the prior close of $0.07. Day range $0.04–$0.07, opened at $0.05.
- Volume was 752.00K shares, 6.6x its 50-day average of 113.48K — unusually heavy trading.
- 52-week range $0.04–$0.07; today's close sits at 80% of that range, 7.7% below the 52-week high.
TVGNW bull case vs bear case (from the data)
- Share count down 96.7% in a year (buybacks).
- Latest fiscal-year net income: loss of $26.28M.
- Insider selling outweighs buying: 12 sales vs 0 open-market buys among the 12 most recent reported insider trades (Form 4, last 12 months).
- High volatility: average daily move of 7.7% over 20 sessions.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
TVGNW latest news & SEC filings
Every SEC filing by or about TVGNW in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 16, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 16, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Saadi Ryan H. received an award of 8,000,000 shares on Sep 14, 2026; now holds 11,705,689
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Desai Kirti received an award of 750,000 shares on Sep 14, 2026; now holds 992,983
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 26, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 5.07 — Reported shareholder vote results.
Aug 24, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$5.76M (prior year -$5.50M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$1.52 (prior year -$1.71) (loss narrowed vs Jun 30, 2025)
Aug 3, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Things to know before you trade TVGNW
- Last results release: Apr 26, 2024 (8-K Item 2.02).
- How much it moves: over the last 20 sessions the average daily move was 7.69% (largest 7.7%). That is a volatile stock.
- Liquidity: about 432.74K shares (≈$27.52K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.06 vs a range of $0.04–$0.07 (80% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 12 sales; latest: Neal Flomenberg sold 501 shares on Mar 13, 2026.
- Latest filings: 8-K Sep 30, 2026; 8-K Sep 16, 2026; 8-K Sep 10, 2026.
- Share count: 6.51M shares outstanding (Aug 10, 2026), -96.7% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
TVGNW market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 0.05 | 0.07 | 0.04 | 0.06 | 752.00K |
| Oct 16, 2026 | 0.05 | 0.07 | 0.06 | 0.07 | 113.48K |
About Tevogen
Tevogen (TVGNW) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in WARREN, NJ. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1860871.
TVGNW board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jeffrey L. Feike | Director | Sep 15, 2026 |
| Keow Lin Goh | Director | Sep 15, 2026 |
| Susan M Podlogar | Director | Sep 15, 2026 |
| Curtis L. Patton | Director | Sep 15, 2026 |
| Ryan H. Saadi | Chief Executive Officer | Sep 16, 2026 |
| Victor J. Sordillo | Director | Sep 15, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Kirti Desai | Chief Financial Officer | Sep 16, 2026 |
| Neal Flomenberg | See Remarks | Mar 17, 2026 |
| Ryan H. Saadi | Chief Executive Officer | Sep 16, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Mar 13, 2026 | Neal Flomenberg | Sale | 501 | $6.40 |
| Mar 13, 2026 | Neal Flomenberg | Sale | 501 | $6.40 |
| Mar 13, 2026 | Neal Flomenberg | Sale | 501 | $6.40 |
| Mar 13, 2026 | Neal Flomenberg | Sale | 501 | $6.40 |
| Mar 11, 2026 | Neal Flomenberg | Sale | 452 | $7.26 |
| Mar 11, 2026 | Neal Flomenberg | Sale | 452 | $7.26 |
| Mar 11, 2026 | Neal Flomenberg | Sale | 452 | $7.26 |
| Mar 11, 2026 | Neal Flomenberg | Sale | 452 | $7.26 |
| Mar 10, 2026 | Neal Flomenberg | Sale | 19 | $7.75 |
| Mar 10, 2026 | Neal Flomenberg | Sale | 19 | $7.75 |
| Mar 10, 2026 | Neal Flomenberg | Sale | 19 | $7.75 |
| Mar 10, 2026 | Neal Flomenberg | Sale | 19 | $7.75 |
TVGNW financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-26.28M | -8.08 | $-12.33M |
| Dec 31, 2024 | — | $-13.73M | -3.50 | $-12.00M |
| Dec 31, 2023 | — | $-60.48M | -2.44 | $-8.17M |
| Dec 31, 2022 | — | $4.41M | — | $-215.40K |
Latest balance sheet: total assets $4.73M, total liabilities $13.62M, cash $0 (as of Jun 30, 2026).
TVGNW earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Apr 26, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Biogen (BIIB)Halozyme Therapeutics (HALO)Vaxcyte (PCVX)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on TVGNW
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 19, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.